Author:
Lahme Sven,Bichler Karl-Horst,Feil Gerhard,Zumbrägel Andreas,Götz Tobias
Reference14 articles.
1. Abbate I, D’Introno A, Cardo G, Marano A, Addabbo L, Musci MD, et al: Comparision of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer. Anticancer Res, 18(5b):3803, 1998.
2. Carpinito GA, Stadler WM, Briggman JV, Chodak GW, Church PA, Lamm DL, et al: Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract. J Urol, 156 (4): 1280, 1996.
3. Chen YT, Hayden CL, Marchand KJ, Makuch RW: Comparison of urine collection methods for evaluating urinary nuclear matrix protein, NMP22, as a tumor marker. J Urol, 158(5): 1899, 1997.
4. Del-Nero A, Esposito N, Curro A, Biasoni D, Montanari E, Mangiarotti B, et al: Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test. Eur Urol, 35 (2):93, 1999.
5. Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, et al: Comparision for screening methods in the detection of bladder cancer. J Urol, 161(2):388, 1999.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献